gvtcx

High Content Screening System

MEDICINES DISCOVERY CATAPULT SERVICES LIMITED Published 23 May 2023 Find a Tender

key details

Value£750,000
Statuscomplete
Category (CPV) 38000000
RegionNorth West
Deadline21 Nov 2022
Procedureopen
OCIDocds-h6vhtk-03655c

Award

SupplierValueDateStatus
Perkin Elmer LAS (UK) LIMITED · · active

description

The Advanced Technologies team at the Medicines Discovery Catapult (MDC) is looking to expand its current advanced microscopy facility to support both our own growing needs and provide the UK SME community access to advanced molecular and cellular imaging.

MDC is aiming purchase a confocal High Content Screening (HCS) instrument based on an automated well-plate inverted microscope, together with confocal and widefield functionalities. It is crucial for the HCS system to be flexible and provide fast and high-resolution imaging of a wide range of experiments.

The instrument should be configured to enable the use of different sample formats (2D and 3D cell models, tissue sections, fixed and live-cell) and experimental types (drug dose responses, live-cell kinetic studies, phenotypic screening, RNA scope), using a large variety of well-plate formats and a wide range of fluorophores. In addition, the HCS instrument must be supplied with a high-end solution for high content image analysis, visualization and handling.

notice history

3 notices published against this procurement.

PublishedTypeRegimeNotice
2 Sept 2022 Prior information notice (F01) Earlier regulations 024651-2022
31 Oct 2022 Contract notice (F02) Earlier regulations 030642-2022
23 May 2023 Contract award notice (F03) Earlier regulations 014693-2023

more from MEDICINES DISCOVERY CATAPULT SERVICES LIMITED

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.